Abstract
The clinical and biological features of acute myeloid leukemia (AML) with 11q23/MLL translocations are well known, but the characteristics of AML with partial tandem duplication of the MLL gene have not been explored comprehensively. In this study, MLL duplication was analyzed, in 81 AML patients without chromosomal abnormalities at 11q23, using Southern blotting, genomic DNA polymerase chain reaction (PCR), reverse-transcription PCR and complementary DNA sequencing. Nine patients showed partial tandem duplication of the MLL gene, including eight (12%) of the 68 with normal karyotype. Seven patients showed fusion of exon 6/exon 2 (e6/e2), one, combination of differentially spliced transcripts e7/e2 and e6/e2, and the remaining one, combination of e8/e2 and e7/e2. Among the patients with normal karyotype, children aged 1 to 15 showed a trend to higher frequency of MLL duplication than other patients (2/5 or 40% vs 6/62 or 10%, P = 0.102). The patients with tandem duplication of the MLL gene had a significantly higher incidence of CD11b expression on leukemic cells than did those without in the subgroup of patients with normal karyotype (75% vs 28%, P = 0.017). There were no significant differences in the expression of lymphoid antigens or other myeloid antigens between the two groups of patients. In adults, the patients with MLL duplication had a shorter median survival time than those without (4.5 months vs 12 months, P = 0.036). In conclusion, partial tandem duplication of the MLL gene is associated with increased expression of CD11b on leukemic blasts and implicates poor prognosis in adult AML patients. The higher frequency of MLL duplication in children older than 1 year, than in other age groups, needs to be confirmed by further studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mrózek K, Heinonen K, de la Chapelle A, Bloomfield CD . Clinical significance of cytogenetics in acute myeloid leukemia Semin Oncol 1997 24: 17–31
Heim S, Mitelman F . Cancer Cytogenetics Wiley-Liss: New York 1995
Rowley JD . Rearrangements involving chromosome band 11q23 in acute leukemia Semin Cancer 1993 4: 377–385
Rabbitts TH . Chromosomal translocations in human cancer Nature 1994 372: 143–149
Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA . A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias Nat Genet 1992 2: 113–118
Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO . Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias Proc Natl Acad Sci USA 1991 88: 10735–10739
Bernard OA, Berger R . Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations Genes Chromosom Cancer 1995 13: 75–85
Rubnitz JE, Behm FG, Downing JR . 11q23 rearrangements in acute leukemia Leukemia 1996 10: 74–82
Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sadberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD . Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations N Engl J Med 1993 329: 909–914
Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD . Prevalence and clinical correlation of MLL gene rearrangements in AML-M4/5 Blood 1994 84: 3776–3780
Lo Coco F, Madelli F, Breccia M, Annino L, Guglielmi C, Petti MC, Testi AM, Alimena G, Croce CM, Canaani E, Cimino G . Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemia Cancer Res 1993 53: 3800–3803
Tien HF, Hsiao CH, Tang JL, Tsay W, Hu CH, Kuo YY, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH, Lin KS . Characterization of acute myeloid leukemia with MLL rearrangements – no increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts Leukemia 2000 14: 1025–1030
Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM . ALL1 partial duplication in acute leukemia Proc Natl Acad Sci USA 1994 91: 6236–6239
Schichman SA, Canaani E, Croce CM . Self-fusion of the ALL1 gene: a new genetic mechanism for acute leukemia JAMA 1995 273: 571–576
Archimbaud D, Charrin C, Magaud JP, Campos L, Thomas X, Fière D, Rimokh R . Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 anomaly or MLL gene rearrangement compared to cased with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint Leukemia 1998 12: 25–33
Cimino G, Rapanotti MC, Elia L, Biondi A, Fizzotti M, Testi AM, Tosti S, Croce CM, Canaani E, Mandelli F, Lo Coco F . ALL-1 gene rearrangements in acute myeloid leukemia: association with M4–M5 French–American–British classification subtypes and young age Cancer Res 1995 55: 1625–1628
Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, Knuutila S, Mrózek K, Oberkircher AR, Marcucci G, de la Chapelle A, Elonen E, Block AW, Rao N, Herzig GP, Powell BL, Ruutu T, Schiffer CA, Bloomfield CD . Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics Cancer Res 1998 58: 55–59
Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, Büchner T, Wörmann B, Hiddemann W, Griesinger F . Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML Leukemia 2000 14: 796–804
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): a report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 460–462
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0) Br J Haematol 1991 78: 325–329
Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin KH, Lin DT . Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia: a study of 235 Chinese patients in Taiwan Cancer Genet Cytogenet 1995 84: 60–68
Mitelman F (ed). ISCN (1995). An International System for Human Cytogenetic Nomenclature S Karger: Basel 1995
Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH . Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML Leukemia 1993 7: 688–695
Huang SY, Tang JL, Liang YJ, Wang CH, Chen YC, Tien HF . Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan Br J Haematol 1997 96: 682–687
Caligiuri MA, Strout MP, Schichman SA, Mrózek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD . Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11 Cancer Res 1996 56: 1418–1425
Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ . MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype Leukemia 1996 10: 774–780
Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, William CL, Cleary ML . HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities Blood 1993 81: 3197–3203
Griesinger F, Jensch O, Podleschny M, Spilker K, Theuerkauf N, Brittinger G, Schnittger S, Wörmann B . Screening for MLL-duplications in unselected pediatric AML Blood 1999 94 (Suppl. 1): 204B
Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ . Defects in yolk sac hematopoiesis in Mll-null embryos Blood 1997 90: 1799–1806
Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, Smith AJH, Rabbitts TH . The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis EMBO J 1999 18: 3564–3574
Caslini C, Shilatifard A, Hess JL . The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation Proc Natl Acad Sci USA 2000 97: 2797–2802
Ma Q, Alder H, Nelson KK, Chatterjee D, Gu Y, Nakamura T, Canaani E, Croce CM, Siracusa LD, Buchberg AM . Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases Proc Natl Acad Sci USA 1993 90: 6350–6354
Nam DK, Honoki K, Yu M, Yunis JJ . Alternative RNA splicing of the MLL gene in normal and malignant cells Gene 1996 178: 169–175
Schnittger S, Wörmann B, Hiddemann W, Griesinger F . Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors Blood 1998 92: 1728–1734
Marcucci G, Strout MP, Bloomfield CD, Caligiuri MA . Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts Cancer Res 1998 58: 790–793
Döhner K, Ulrich R, Liebisch C, Fröhling S, Schlenk RF, Döhner H . Prognostic significance of partial tandem duplications of the MLL gene in acute myeloid leukemia with normal cytogenetics: a study within a multicenter treatment trial Blood 1999 94 (Suppl. 1): 499A
de Greef GE, van Putten WLJ, Beije MJA, Drunen EV, Smit EME, Slater RM, Beverloo HB . MLL gene tandem duplication in adult patients with acute myeloid leukemia and normal karyotype does not have prognostic implications Blood 1999 94 (Suppl. 1): 500A
Acknowledgements
This study was supported in part by grants from the National Science Council of the Republic of China, NSC 89-2314-B002-341.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shiah, HS., Kuo, YY., Tang, JL. et al. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia 16, 196–202 (2002). https://doi.org/10.1038/sj.leu.2402352
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402352
Keywords
This article is cited by
-
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
Blood Cancer Journal (2023)
-
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
BMC Cancer (2019)
-
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
Clinical Epigenetics (2018)
-
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
Blood Cancer Journal (2018)
-
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
Blood Cancer Journal (2018)